Scimago Lab
powered by Scopus
eISSN: 1941-5923


Get your full text copy in PDF

Casual or Causal? Two Unique Cases of Hodgkin’s Lymphoma: A Case Report and Literature Review

Faizan Malik, Naveed Ali, Syed Imran Mustafa Jafri, Christian Fidler

(Department of Internal Medicine, Abington Hospital Jefferson Health, Abington, USA)

Am J Case Rep 2017; 18:553-557

DOI: 10.12659/AJCR.903118

BACKGROUND: Immunosuppressive diseases and therapies have long been connected to risk of malignancies, especially lymphoma. With some diseases and drugs, the association is well established but the data is mostly anecdotal because of the rarity of the situation.
CASE REPORT: We present 2 rare cases. The first patient had psoriasis, was on etanercept, and developed Hodgkin’s lymphoma. This case is rare because psoriasis and etanercept do not usually cause lymphoma, and if they do, it is predominantly Epstein-Barr virus-positive non-Hodgkin’s lymphoma. The second patient had acquired immune deficiency syndrome (AIDS) and developed Hodgkin’s lymphoma while on highly active antiretroviral therapy (HAART). This case is rare because AIDS mostly causes Kaposi’s sarcoma or non-Hodgkin’s lymphoma due to immunosuppression, but whether it is AIDS or HAART therapy that leads to development of Hodgkin’s lymphoma in these patients is not clear.
CONCLUSIONS: Immunosuppression seems to be the primary culprit leading to lymphomas in these cases. The exact mechanism is still not completely understood.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree